Metabolic Health Articles - Page 38

Novo Nordisk's FDA-Approved GLP-1s Now on Hims & Hers

Hims & Hers Health, Inc. has partnered with Novo Nordisk to bring a broad assortment of FDA-approved GLP-1 medications to eligible customers, including the groundbreaking Wegovy® pill. This collaboration simplifies access with affordable prices, expanded doses, and diverse delivery methods. As the largest global consumer health platform for these approved meds, Hims & Hers is transforming weight management options.

Shotlee·Mar 26, 2026·4 min read

Peptide Therapy

GLP-1R Regulates Blood Pressure via Kidney VSMCs, Study Finds

Researchers have pinpointed that GLP-1 receptors (GLP-1R) in kidney vascular smooth muscle cells play a crucial role in blood pressure regulation. In mouse studies, semaglutide lowered BP only when these receptors were intact, highlighting a novel pathway independent of weight loss. This could reshape our understanding of GLP-1 therapies in hypertension.

Shotlee·Mar 26, 2026·5 min read

GLP-1 Medications

Ozempic Goes Generic Worldwide, But Not in U.S. Until 2030

Ozempic, the blockbuster semaglutide drug from Novo Nordisk, is set to go generic in India as early as this weekend, with China, Brazil, Turkey, and South Africa following. This could drop prices to $15 per month, opening access to millions with obesity and diabetes. Meanwhile, U.S. and Europe face delays until 2030 due to patent extensions.

Shotlee·Mar 26, 2026·5 min read

Patient Stories & Warnings

How Layla Taylor Got GLP-1 in Utah: Eating Disorder Warning

Reality star Layla Taylor shares her concerning experience obtaining a GLP-1 prescription with alarming ease in Utah, revealing how the medication became an 'unhealthy crutch' amid her long-term battle with an eating disorder. Her story highlights critical gaps in patient screening and mental health considerations.

Shotlee·Mar 26, 2026·7 min read

GLP-1 Medications

Dr. Trehan Warns: Generic GLP-1 Drugs Shouldn't Be OTC

As generic GLP-1 drugs flood the Indian market post-patent expiry, Dr. Naresh Trehan warns they shouldn't be available over-the-counter due to serious side effects. Government advisories stress medical supervision to prevent misuse. Experts like Dr. Gupta and Dr. Bhattacharya highlight risks of self-medication with semaglutide and liraglutide.

Shotlee·Mar 26, 2026·6 min read

GLP-1 Travel & Logistics

Traveling with GLP-1s Like Wegovy: Key Tips Before Flying

More people are using GLP-1 injectables like Wegovy for weight management, but air travel poses refrigeration challenges. As a flight attendant, I've fielded countless requests to store meds in plane fridges—here's why that's not possible and the practical solutions that work.

Shotlee·Mar 25, 2026·5 min read

GLP-1 Medications

What Happens to Your Body on Ozempic Without Exercising: Study Insights

Wondering what happens to your body when you take Ozempic without exercising? A recent study in Sports Medicine analyzed liraglutide users and found that while GLP-1 drugs promote weight loss, skipping exercise leads to poorer fitness outcomes. Exercise plus the drug delivers the best results for health and function.

Shotlee·Mar 25, 2026·5 min read

Health Tech & GLP-1 Innovations

VITL Raises $7.5M to Overhaul Cash-Pay Clinic E-Prescribing Amid GLP-1 Boom

Amid the GLP-1 boom driving med-spas and weight loss clinics, VITL has landed $7.5M in Series A funding to revolutionize e-prescribing for cash-pay providers. The platform slashes prescription times to seconds with real-time pricing and tracking from compounding pharmacies. With 630 clinics onboard and eight-figure ARR, VITL is poised to scale in the growing peptide and aesthetic market.

Shotlee·Mar 25, 2026·5 min read

GLP-1 Medications

FDA Approves Triple Max Dose of Wegovy: 7.2mg Now Available

The FDA just greenlit a groundbreaking higher dose of Wegovy, tripling the previous maximum to 7.2 milligrams for enhanced weight management. Patients saw up to 21% body weight loss, with unique cardiovascular protections. Here's what this means for obesity treatment and access.

Shotlee·Mar 25, 2026·5 min read

Metabolic Health

Latest Articles

Novo Nordisk's FDA-Approved GLP-1s Now on Hims & Hers

GLP-1R Regulates Blood Pressure via Kidney VSMCs, Study Finds

Ozempic Goes Generic Worldwide, But Not in U.S. Until 2030

How Layla Taylor Got GLP-1 in Utah: Eating Disorder Warning

Dr. Trehan Warns: Generic GLP-1 Drugs Shouldn't Be OTC

Traveling with GLP-1s Like Wegovy: Key Tips Before Flying

What Happens to Your Body on Ozempic Without Exercising: Study Insights

VITL Raises $7.5M to Overhaul Cash-Pay Clinic E-Prescribing Amid GLP-1 Boom

FDA Approves Triple Max Dose of Wegovy: 7.2mg Now Available

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less

Ozempic, Mounjaro & More: Yale Study Exposes Risky Online GLP-1 Prescribing

GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & Allodynia

Beyond Healthspan: The New Midlife Goal for Men

Ozempic and Similar Weight-Loss Medications Linked to 30% Lower Breast Cancer Risk